Last updated 2026-06-18
- Acquired by Alcon Pharmaceuticals, Jul 2024
- Raised $19.7M grant led by European Innovation Council (EIC), Dec 2021
- Raised $12.3M funding round led by CR-CP Life Science Fund, Jul 2020
Total raised
$38.4M
Last: Grant 2021-12
Stage
Acquired
Founded
2013
Headcount
22
HQ
Yavne, Israel
Sector
Health Tech & Life Sciences
About
BELKIN Laser is developing a contact-free laser procedure for the primary treatment of glaucoma. The device delivers a single laser beam, with a pulse duration of a few nanoseconds, 120 times in about a second to the limbus, enhancing intraocular fluid drainage and lowering intraocular pressure, a key risk factor for glaucoma. Suitable for use in clinics and hospitals, this technology serves as an initial or adjunctive treatment for glaucoma, including both open angle and angle closure types.
The company received FDA Clearance for the Eagle Device.
Funding history · 7 rounds · $38.4M total
2021-12
Grant
$19.7M
2021-09
Undisclosed
2020-07
2017-04
2016-03
Grant
$2.8M
2015-07
2013-04
Q&A
- What is BELKIN Vision's primary focus?
- BELKIN Vision is developing a contact-free laser procedure for the primary treatment of glaucoma, utilizing a device that delivers a single laser beam to enhance intraocular fluid drainage and lower intraocular pressure.
- When was BELKIN Vision founded?
- BELKIN Vision was founded in March 2013.
- What is the current status of BELKIN Vision?
- BELKIN Vision was acquired by Alcon Pharmaceuticals in July 2024 and is currently inactive.
- How much funding has BELKIN Vision raised in total?
- BELKIN Vision has raised a total of $38,440,000 USD.
- Which investors participated in BELKIN Vision's July 2020 funding round?
- The July 2020 funding round for BELKIN Vision included.
- What was BELKIN Vision's most recent funding event?
- In December 2021, BELKIN Vision received a grant of $19,740,000 USD from the European Innovation Council (EIC).
- What is the employee count for BELKIN Vision?
- BELKIN Vision has 11-50 employees.
- Who is the founder and medical director of BELKIN Vision?
- Prof. Belkin is the Founder & Medical Director of BELKIN Vision.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
SensingLaser
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
ophthalmologyhospitalsnon-invasivemedical-deviceslasersglaucomapain-freepain-freehealthcare-providersclinicsmedical-technologieseye-diseasesdoctorsoptronicsautomationtreatmentseye-trackingalgorithms
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/18529552 | |
| YouTube | youtube.com/channel/UCb5LCywmfIlZpaJFZbTSHOQ |
Identifiers & details
| Former names | Belkin Laser |
|---|---|
| Founded | 2013-3 |
| Employees (exact) | 22 |
| Status reason | Acquired (Inactive) by Alcon Pharmaceuticals on Jul 2024 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Alcon Pharmaceuticals 2024-07
Radar intelligence
Patents
| EPO | 16 |
|---|